If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
287.50    0.00 (0.00%)
Bid:
285.00
Ask:
290.00
Spread: 5.00 (1.754%)
Market Cap: £86.46m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Director/PDMR Shareholding

30 Mar 2007 15:37

Molins PLC30 March 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS 1. Name of the issuer MOLINS PLC 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) BOTH 3. Name of person discharging managerial responsibilities/director MR PETER JOHN BYROM 4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person ME PETER JOHN BYROM HIMSELF AND CONNECTED PERSON MELANIE SIGNE BYROM 5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest PERSONS REFERRED TO IN 3 OR 4 ABOVE 6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares ORDINARY SHARES OF 25p 7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them AFTER TRANSACTION: MR PETER JOHN BYROM 359,000 MR PETER JOHN BYROM OSB&SMB 2,400 MELANIE SIGNE BYROM 30,294 8. State the nature of the transaction SALE OF SHARES 9. Number of shares, debentures or financial instruments relating to shares acquired NIL 10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) N/A 11. Number of shares, debentures or financial instruments relating to shares disposed 27,706 12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 0.14 13. Price per share or value of transaction £1.808089 14. Date and place of transaction 29 MARCH 2007, LONDON 15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 391,694 16. Date issuer informed of transaction 29 MARCH 2007 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17. Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant of the option 20. Description of shares or debentures involved (class and number) 21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise 22. Total number of shares or debentures over which options held following notification 23. Any additional information 24. Name of contact and telephone number for queries ANDREW PENNYCUICK - 01908 219039 Name and signature of duly authorised officer of issuer responsible for making notification ANDREW PENNYCUICK Date of notification: 30 MARCH 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Mar 20207:00 amRNSFull year results
3rd Mar 202012:48 pmRNSHolding(s) in Company
4th Feb 202011:35 amRNSNotice of Results
9th Jan 202011:07 amRNSSecond Price Monitoring Extn
9th Jan 202011:01 amRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSFull year trading update
9th Dec 20197:00 amRNSChange of Adviser
5th Sep 20197:00 amRNSHalf-year results
8th Aug 20192:03 pmRNSNotice of Results
16th Jul 201911:07 amRNSSecond Price Monitoring Extn
16th Jul 201911:01 amRNSPrice Monitoring Extension
16th Jul 20197:00 amRNSTrading Update
12th Jun 20193:30 pmRNSAwards under Long Term Incentive Plan
11th Jun 20197:00 amRNSPension scheme valuation update
3rd May 20193:15 pmRNSDirector/PDMR Shareholding
3rd May 20191:23 pmRNSTR-1
3rd May 20191:19 pmRNSAwards under Deferred Share Plan
2nd May 20194:14 pmRNSResult of AGM
1st May 20197:00 amRNSAcquisition of Lambert and Trading Update
3rd Apr 20193:57 pmRNSPosting of 2018 Annual Report and Notice of AGM
5th Mar 20197:00 amRNSFinal results for the year ended 31 December 2018
30th Jan 20197:00 amRNSNotice of Results
7th Jan 20197:00 amRNSYear-end trading update
1st Nov 20187:00 amRNSDirectorate Appointment
6th Sep 20185:21 pmRNSDirector/PDMR Shareholding
6th Sep 20184:41 pmRNSSecond Price Monitoring Extn
6th Sep 20184:36 pmRNSPrice Monitoring Extension
6th Sep 20187:00 amRNSHalf-year results
20th Aug 201810:55 amRNSNotice of Results - Replacement
3rd Aug 201811:30 amRNSNotice of Results
18th Jul 20185:49 pmRNSHolding(s) in Company
18th Jul 201811:06 amRNSSecond Price Monitoring Extn
18th Jul 201811:01 amRNSPrice Monitoring Extension
18th Jul 20187:00 amRNSHalf- Year Trading Update
22nd Jun 20187:00 amRNSDirectorate Change
3rd May 20185:12 pmRNSDirectorate Change
19th Apr 20182:07 pmRNSResult of AGM and Board Changes
19th Apr 20187:00 amRNSAGM statement and Board Change
21st Mar 201810:02 amRNSPosting of 2017 Annual Report and Notice of AGM
16th Mar 201811:38 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSFinal Results for the year to 31 December 2017
14th Feb 20187:00 amRNSNotice of Results
26th Jan 20187:00 amRNSChange of name to Mpac Group plc
22nd Jan 201811:11 amRNSResult of General Meeting and Change of Name
3rd Jan 201812:28 pmRNSProposed name change and notice of General Meeting
2nd Jan 20184:20 pmRNSDisposal
5th Dec 20177:00 amRNSDisposal
10th Oct 20173:39 pmRNSChange of Registered Office
14th Sep 201711:16 amRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.